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INTRODUCTION
Colonoscopic polypectomy and surveillance are important to 
prevent colorectal cancer.1-3 Guidelines recommend polypecto-
my surveillance intervals according to risk stratification, based 
on polyp characteristics.4 However, the present guidelines as-
sume adequate bowel cleansing, proper withdrawal time, and 
complete cecal inspection at the qualifying colonoscopy, and 
did not consider other information about the patient or proce-
dure. 
Guidelines defined high-risk polyps as adenoma with villous 
histology, high-grade dysplasia (HGD), ≥10 mm, or 3 or more 
adenomas. The risk of high-risk polyps was 1.3–2.4% within 5 
years of a negative colonoscopy, but this risk increases by 11.9% 
with three or more adenomas <10 mm.5-10 According to polyp 
size, the risk of high-risk polyp is 7.7% for polyps <5 mm, 15.9% 
for polyps 10–19 mm, and 19.3% for polyps >20 mm.11 There-
fore, polypectomy surveillance guidelines recommend follow-
up of less than 3 years for patients with high-risk polyps at 
baseline colonoscopy. Although not all patients with high-risk 
polyps progress clinically, many endoscopists tend to perform 
surveillance colonoscopy at intervals shorter than 3 years rec-
ommended by the guidelines. In fact, Martínez, et al.12 report-
ed that the 1-year detection rate of high-risk polyps was 3.8% 
in lower-risk patients and 11.2% in high-risk patients. There-
fore, a more detailed risk stratification of polypectomy surveil-
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lance guidelines appears to be needed.
Previous studies of recurrent high-risk polyps have defined 
the index colonoscopy as one or more adenomas or negative 
finding.5-14 However, we thought it necessary to evaluate the re-
currence of high-risk polyps after an index colonoscopy finding 
of high-risk polyps. Therefore, we compared patients who had 
recurrent high-risk polyps with those with low-risk or no polyps 
during surveillance after an index colonoscopy with high-risk 
polyps. We then evaluated risk factors for recurrent high-risk 
polyps. Identification of more relative risk factors is important 
for adequate surveillance of high-risk polyps and will contrib-
ute to lower healthcare costs. 
MATERIALS AND METHODS
Among 5472 patients who underwent more than two colonos-
copies from 2005 to 2011 at Severance Hospital, 2672 patients 
had polyps found during their first colonoscopy. Of these, we 
enrolled 434 consecutive patients with high-risk polyps (ade-
noma ≥10 mm, ≥3 adenomas, ≥20% villous histology, or HGD) 
during first colonoscopy. The following clinical data were col-
lected retrospectively from medical records: 1) patient charac-
teristics including gender, age, body mass index, family history 
of colorectal cancer (CRC) or polyps, and personal history of 
aspirin and/or nonsteroidal anti-inflammatory drug (NSAID) 
use; 2) procedure information including bowel cleanliness, 
endoscopist experience, colonoscopy withdrawal time, pres-
Table 1. Baseline Characteristics of the Study Patients
All patients High-risk → no or low-risk High-risk → high-risk p value
Number (%) 434 383 (88.2) 51 (11.8)
Patient factors
Male (%) 336 (77.4) 290 (75.7) 46 (90.2) 0.02
Age (yrs) 61.0±8.6 60.7±8.7 63.2±7.9 0.058
Body mass index (kg/m2) 24.0±2.9 24.1±2.8 23.5±3.0 0.183
Family history of CRC (%) 37 (8.5) 36 (9.4) 1 (2.0) 0.074
Family history of polyps (%) 23 (5.3) 20 (5.2) 3 (5.9) 0.843
Aspirin and/or NSAID use (%) 70 (16.1) 60 (15.7) 10 (19.6) 0.477
Procedure factors
Bowel preparation (%) 0.005
Good or fair 351 (81.0) 317 (83.0) 34 (66.7)
Poor 82 (19.0) 65 (17.0) 17 (33.3)
Endoscopist (%) 0.133
Experienced colonoscopist 230 (53.0) 208 (54.3) 22 (43.1)
Fellow 204 (47.0) 175 (45.7) 29 (56.9)
Withdrawal time (min) 24.2±17.8 23.6±17.7 28.9±17.6 0.043
Diverticular disease (%) 57 (13.1) 50 (13.1) 7 (13.7) 0.894
Failed colonoscopy (%) 7 (1.6) 5 (1.3) 2 (3.9) 0.164
Polyp factors
Interval period (yrs) 1.5±0.8 1.5±0.8 1.6±0.9 0.27
Size (max) 14.5±9.1 14.8±9.3 12.2±7.7 0.054
Site (%) 0.859
Left (DC–R) 255 (59.0) 226 (59.3) 29 (58.0)
Right (C–SF) 176 (41.0) 155 (40.7) 21 (42.0)
Polyp number
Total number (%) 3.7±3.2 3.5±3.1 5.7±3.6 <0.001
1–2 186 (42.9) 180 (47.0) 6 (11.8) <0.001
3–9 225 (51.8) 189 (49.3) 36 (70.6)
≥10 23 (5.3) 14 (3.7) 9 (17.6)
Number of polyps ≥1 cm 1.0±1.1 1.0±1.0 0.9±1.5 0.593
Pathology (%) 0.166
Adenoma 187 (43.1) 158 (41.3) 29 (56.9)
Villous 83 (19.1) 76 (19.8) 7 (13.7)
High grade 164 (37.8) 149 (38.9) 15 (29.4)
CRC, colorectal cancer; NSAID, nonsteroidal anti-inflammatory drug; DC, descending colon; R, rectum; C, cecum; SF, splenic flexure.
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ence of diverticular disease, and success/failure of colonosco-
py; and 3) polyp information including size, location, number, 
pathological diagnosis, and interval between initial and sur-
veillance colonoscopies. Bowel cleansing was accomplished 
with 4 L of a polyethylene glycol-electrolyte solution (Colon-
lyte; Taejun, Seoul, Korea). Adequacy of bowel cleansing was 
classified using a three-point scale (good: dry colon or small 
volume of clear liquid; fair: large volume of clear liquid or 
minimal semi-solid residue with clear liquid; poor: significant 
amount of solid residue).15 Endoscopists were classified as ex-
perienced (>1000 colonoscopic cases) or inexperienced (≤100 
colonoscopic cases). Withdrawal time was defined as time re-
quired for withdrawal of the colonoscope from cecum to anus, 
including polypectomy. We evaluated all removed polyps with-
out disuse. Polyp size was determined by comparison with an 
open biopsy forceps. In cases with multiple polyps, polyp size 
was defined as size of the largest polyp. Location was catego-
rized relative to the splenic flexure: 1) right colon (cecum, as-
cending and transverse colons) or 2) left colon (rectum, sigmoid 
and descending colons). In cases with multiple polyps, polyp lo-
cation was defined as that of the index adenoma. Index polyp 
was based on the largest polyp, or polyps with HGD or villous 
histology if all polyps were <1 cm.16 Baseline colonoscopy was 
defined as the first colonoscopy showing a high-risk polyp. For 
patients examined in less than 6 months of the baseline colo-
noscopy, the additional polyps were included as part of the 
baseline colonoscopy. Surveillance colonoscopy was defined as 
a colonoscopy repeated within more than 1 year of the index 
colonoscopy. To evaluate factors affecting recurrence of high-
risk polyps after a previous colonoscopy finding of high-risk pol-
yp, patients with recurrent high-risk polyps were compared with 
those who had low-risk or no polyps during surveillance after an 
index colonoscopy with high-risk polyps. 
Patient characteristics are presented as mean±standard devi-
ation or n (%), as appropriate. The independent t-test or Mann-
Whitney U test was used to compare continuous variables, and 
χ2 test or Fisher’s exact test was used to compare categorical 
variables. Multivariate logistic regression was performed to 
Table 2. Univariate and Multivariate Logistic Regression for the Factors Associated with Recurrent High-Risk Polyps
Univariate Multivariate
p value OR 95% CI p value
Patient factors
Gender 0.026
Female 1
Male 2.757 1.015–7.489 0.047
Age 0.059
Body mass index 0.183
Family history of CRC 0.108
Family history of polyps 0.843
Aspirin and/or NSAID use 0.478
Procedure factors
Bowel preparation 0.006
Good or fair 1
Poor 2.408 1.238–4.662 0.010
Endoscopist (experienced colonoscopist, fellow) 0.135
Withdrawal time 0.052
Diverticular disease 0.894
Failed colonoscopy 0.185
Polyp factors
Interval period 0.270
Size (max) 0.055
Site [left (DC–R), right (C–SF)] 0.831
Polyp number
Total number <0.001 1.150 1.069–1.237 <0.001
1–2 <0.001
3–9
≥10
Number of polyps ≥1 cm 0.592
Pathology (adenoma, villous, high grade) 0.079
OR, odds ratio; CI, confidence interval; CRC, colorectal cancer; NSAID, nonsteroidal anti-inflammatory drug; DC, descending colon; R, rectum; C, cecum; SF, 
splenic flexure.
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identify risk factors for recurrence of high-risk polyps. Variables 
that were predictive at the 0.05 level by using a univariate analy-
sis were entered into the final multivariate analysis. A p-value of 
<0.05 was considered significant, and all statistical analyses 
were performed using SPSS software version 12.0 (SPSS Inc., 
Chicago, IL, USA).
RESULTS
Baseline characteristics
A total of 434 patients (336 men, 98 women) underwent surveil-
lance colonoscopy after a previous colonoscopy finding of 
high-risk polyp. Baseline characteristics of the patients are 
summarized in Table 1. Mean age was 61.0±8.6 years, and mean 
follow-up was 17.6±9.6 months. Recurrent high-risk polyps dur-
ing surveillance colonoscopy were observed in 51 (11.8%) pa-
tients. Initial colonoscopy results of 51 patients with recurrent 
high-risk polyps were compared with those of 383 patients with 
low-risk or no polyps during surveillance. Gender, bowel prep-
aration, withdrawal time, and polyp number were different be-
tween two groups.
Factors associated with recurrent high-risk polyps
We analyzed risk factors of recurrent high-risk polyps using lo-
gistic regression (Table 2). Results of univariate and multivari-
ate analysis showed that male gender, poor bowel preparation, 
and a higher number of adenoma were independent risk fac-
tors for recurrence (p=0.047, 0.01, and <0.001, respectively). En-
doscopist experience and polyp size, location, and pathology 
were not risk factor of recurrent high-risk polyps.
Detection rate of recurrent high-risk polyp in cases 
without three risk factors
We evaluated the recurrence rate of high-risk polyp in cases 
without the three risk factors described above (Table 3). Recur-
rence rates of high-risk polyps for the non-risk factors such as 
female gender, proper bowel preparation, and 1–2 polyps were 
5.0%, 9.6%, and 3.2%, respectively. Evaluation of combinations 
of non-risk factors showed that the recurrence rate of high-
risk polyps decreased by 3.7% in females with proper bowel 
preparation, 3.0% in females with 1–2 polyps, and 1.9% for 
males with proper bowel preparation and 1–2 polyps. Recur-
rent high-risk polyps were not observed in patients with all 
three non-risk factors.
Comparison of polyp characteristics between  
high-risk polyps in initial colonoscopy and those  
in surveillance colonoscopy
High-risk polyps that recurred during surveillance had in-
creased numbers of small adenomas, low-risk pathology, and 
Table 3. Actual Risk for Recurrence of High-Risk Polyp in Cases without 
Three Risk Factors
Factor 
number
Non-risk factors
High risk polyp/ 
non-risk factor, n (%)
1
Female 5/99 (5.0)
Proper bowel preparation 34/352 (9.6)
1–2 polyps 6/187 (3.2)
2
Female+proper bowel preparation 3/80 (3.7)
Female+1–2 polyps 2/66 (3.0)
Proper bowel preparation+1–2 polyps 3/157 (1.9)
3
Female+proper bowel preparation+ 
  1–2 polyps
0/54 (0)
Table 4. Comparison of Polyp Characteristics between High-Risk Polyps Detected by Initial Colonoscopy and Those Detected by Surveillance Colo-
noscopy
First high-risk polyp Second high-risk polyp p value
n 434 51
Size (max), mm 14.5±9.1 11.8±7.2 0.015
Site
Left (DC–R) 255 (58.8%) 23 (45.1%) 0.055
Right (C–SF) 176 (40.6%) 28 (54.9%)
Polyp number
Total number 3.7±3.2 3.1±1.9 0.05
1–2 186 (42.9%) 20 (39.2%) 0.451 
3–9 225 (51.8%) 30 (58.8%)
≥10 23 (5.3%) 1 (2.0%)
Number of polyps >1 cm 1.0±1.1 0.7±0.5 0.031
Pathology
Adenoma 187 (43.1%) 38 (74.5%) <0.001
Villous 83 (19.1%) 2 (3.9%)
High-grade 164 (37.8%) 11 (21.6%)
DC, descending colon; R, rectum; C, cecum; SF, splenic flexure.
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examinations. However, colonoscopy is not always performed 
optimally. Therefore, polypectomy surveillance guidelines 
should consider not only polyp characteristics but also factors 
related to the procedure and patient. In this study we identified 
for the first time the following risk factors related to recurrence 
of high-risk polyps during surveillance: male gender, poor bowel 
preparation, and higher number of adenoma. 
The 2012 post-polypectomy surveillance guidelines estab-
lished by the United States Multi-Society Task Force (USMSTF) 
recommended repeat colonoscopy within 1 year if the bowel 
preparation was poor.4 Poor bowel preparation occurs in >20% 
of all colonoscopic examinations.17-19 Previous studies reported 
that the rate of missing advanced neoplasia was 18–27% after 
colonoscopy with poor bowel preparation.20,21 In the present 
study, 82 of all patients (18.9%) had poor bowel preparation 
and the mean interval of repeated colonoscopy was 1.5 years. 
Nineteen of 82 patients (23.2%) with poor bowel preparation 
underwent repeated colonoscopy within 1 year. The rate of 
poor bowel preparation for patients with recurrent high-risk 
polyps was higher than that of patients with low-risk or no pol-
yps during surveillance (33.3% vs. 17.0%, respectively). There-
fore, patients with poor bowel preparation and high-risk polyps 
need a shorter surveillance interval. 
Martínez, et al.13 and Bonithon-Kopp, et al.14 earlier reported 
that the risk of high-risk polyps during surveillance was higher 
among male. In addition, USMSTF guidelines added male 
gender as a risk factor for high-risk polyps.4 The present study 
also found that male patients were more likely to have recurrent 
high-risk polyps than low-risk or no polyps during surveillance. 
Thus, male gender is an independent risk factor for recurrent 
high-risk polyps, as well as occurrence of high-risk polyps. 
The pooling of eight prospective studies with the finding of 
adenomas at baseline colonoscopy revealed that with each ad-
fewer total adenomas, but did not differ in location compared 
with polyps found during initial colonoscopy (Table 4). Of the 
434 patients with high-risk polyps, 304 patients had adeno-
mas ≥10 mm (70.0%), 284 patients had >3 adenomas (57.1%), 
and 247 patients had high-risk pathology such as villous his-
tology or HGD (56.9%) (Fig. 1). Rates of recurrence for high-
risk polyps was 28/304 (9.2%) patients with adenoma ≥10 mm, 
45/284 (15.8%) patients with >3 adenomas, and 22/247 (8.9%) 
patients with high-risk histology. In addition, 96.4% of patients 
with high-risk polyps with adenoma ≥10 mm at initial colonos-
copy had recurrent high-risk polyps with adenomas ≥10 mm, 
66.7% of patients with high-risk polyps with >3 adenomas had 
recurrent high-risk polyps with >3 adenomas, and 100% of pa-
tients with high-risk polyps with high-risk pathology had re-
current high-risk polyps with adenoma ≥10 mm. In cases of 
high-risk pathology, recurrence rates of high-risk polyps were 
7/83 (8.4%) patients with villous histology and 15/165 (9.1%) 
patients with HGD (data not shown).
DISCUSSION
The present study is novel in that the baseline colonoscopy find-
ing was high-risk polyps, whereas most previous studies defined 
index colonoscopy as one or more adenomas or negative find-
ing.5-14 We compared patients with recurrent high-risk polyps 
with those who had low-risk or no polyps during surveillance. In 
addition, we identified relative risk factors for recurrent high-
risk polyps. 
The 2013 post-polypectomy surveillance guidelines developed 
by the European Society of Gastrointestinal Endoscopy recom-
mended a 3-year repetition of surveillance colonoscopy in pa-
tients with high-risk adenomas at first or subsequent surveillance 
Fig. 1. Distribution of repeated high-risk polyps according to size, number, and pathology. The recurrence rate of high-risk polyps was higher in patients 
with higher numbers of adenomas (15.8%) than those with larger adenomas (9.2%) or high-risk pathology (8.9%). 
Size (304, 70.0%)
1st high risk polyps 2nd high risk polyps
28 (9.2%) Number (11, 39.3%)
Number (30, 66.7%)
Number (11, 50.0%)
Size (27, 96.4%)
Size (28, 62.2%)
Size (22, 100%)
Pathology (9, 32.1%)
Pathology (11, 24.4%)
Pathology (9, 40.9%)
Number (284, 57.1%) 45 (15.8%)434
Pathology (247, 56.9%) 22 (8.9%)
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ditional adenoma, there is a linear increase in risk for advanced 
metachronous neoplasia: 8.6% for 1 adenoma, 12.7% for 2 ade-
nomas, 15.3% for 3 adenomas, 19.6% for 4 adenomas, and 
24.1% for >5 adenomas.13 A previous study of 895 patients with 
a baseline neoplasia of <10 mm reported that the risk of ad-
vanced neoplasia was 4.6% for 1–2 adenomas and 11.9% for >3 
adenomas.5 In the present study, the risk of recurrent high-risk 
polyps was 3.2% for 1–2 adenomas, 16% for 3–9 adenomas, and 
39.1% for >10 adenomas. As shown in Fig. 1, the recurrence rate 
of high-risk polyps was higher in patients with higher numbers 
of adenomas (15.8%) than those with larger adenomas (9.2%) 
or high-risk pathology (8.9%).
Larger polyps were a risk factor for recurrent high-risk polyps 
in numerous previous studies, defining the index colonoscopy 
as one or more adenomas or a negative finding.3,5,11,22,23 Al-
though most studies reported size as a significant factor, some 
did not. Neither van Stolk, et al.24 nor Bonithon-Kopp, et al.14 
found size to be a significant predictor of metachronous ad-
vanced adenomas. Likewise, polyp size was not a risk factor for 
recurrent high-risk polyps in the present study. These results 
suggest that a multiplicity of polyps might be considered a 
more important factor than size or pathology for surveillance 
intervals for high-risk polyps. 
Interestingly, the combination of three non-risk factors de-
creased recurrence of high-risk polyps, and there were no re-
current high-risk polyps in patients with all three non-risk 
factors (Table 3). The results confirm these three risk factors 
and suggest that risk stratification is needed to determine sur-
veillance intervals for patients with high-risk polyps. At a min-
imum, the surveillance interval for patients without any of the 
three risk factors should differ from that of patients with one 
or more risk factors. 
This study has several limitations. First, we could not pre-
cisely analyze withdrawal time as a possible risk factor for re-
current high-risk polyps, because withdrawal time included 
polypectomy time. Second, we had no information of alcohol 
taking and smoking in our data. Third, this study was retro-
spective in design with a relatively small sample size. There-
fore, a large, multicenter, prospective study will be necessary 
in the future to confirm these risk factors for recurrence of 
high-risk polyps.
In conclusion, patients who are male, and have poor bowel 
preparation and multiplicity of polyps are more likely experi-
ence recurrent high-risk polyps compared with patients with-
out these factors, suggesting that risk stratification for ade-
quate surveillance is needed, based on these three risk factors. 
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